Open AccessAn open science pathway for drug marketing authorization—Registered drug approval
Author(s) -
Florian Naudet,
Maximilian Siebert,
Rémy Boussageon,
Ioana A. Cristea,
Erick H. Turner
Publication year - 2021
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1003726
Subject(s) - medicine , clinical trial , marketing authorization , approved drug , family medicine , clinical research , alternative medicine , drug , pharmacology , bioinformatics , biology , pathology
Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom